EGFR and oropharynx squamous cell carcinoma: Increased expression of nuclear EGFR is linked to poor clinical outcome in patients with breast carcinomas (Lo et al, 2005c) and oropharyngeal squamous cell carcinomas (Psyrri et al, 2005).